On the issue of efficacy and safety of the long-term use of darolutamide in combination therapy in patients with non-metastatic castration-resistant prostate cancer (on the example of one clinical case)

For citation: Semenov A.V. On the issue of efficacy and safety of the long-term use of darolutamide in combination therapy in patients with non-metastatic castration-resistant prostate cancer (on the example of one clinical case). Clinical review for general practice. 2024; 5 (12): 32–37 (In Russ.). DOI: DOI: 10.47407/kr2024.5.12.00534

All accepted articles publish licensed under a Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.